MindBio Therapeutics Positions Voice AI Kiosks for Growth in Workplace Safety Markets
Source: Streetwise Reports  (6/13/26)
MindBio Therapeutics advances prototype Edge AI kiosks for non-invasive intoxication and fatigue detection, targeting high-growth opportunities in mining, aviation, and construction sectors amid expanding biotech and AI markets. More >

MindBio Therapeutics Positions Voice AI Technology for Growth in Safety-Critical Sectors
Source: Streetwise Reports  (6/12/26)
Explore how MindBio Therapeutics is advancing voice-based AI detection for intoxication across mining, aviation, and other industries, backed by strong market trends and analyst targets. More >

MindBio Therapeutics Advances AI Voice Tech for Workplace Safety in Growing Biotech and AI Detector Markets
Source: Streetwise Reports  (6/12/26)
MindBio Therapeutics delivers first prototype Edge AI kiosks for non-invasive intoxication and fatigue detection, positioning the company in high-growth sectors including mining, aviation, and construction, while analysts highlight significant upside potential. More >

Biotech Firm Launches Massive AI Safety Solution for Zero-Tolerance Industries
Source: Streetwise Reports  (6/11/26)
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) delivers first Edge AI intoxication detection kiosk prototypes for mining, aviation, and construction safety screening. More >

Biotech Firm Deploys Revolutionary Intox AI, Unlocking Billion-Dollar Industrial Safety Opportunity
Source: Streetwise Reports  (6/10/26)
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) launches Intox AI, detecting intoxication via voice, targeting mining and aviation in a US$2.06B market. More >

Grey Matters Health Positions for Growth in Expanding Alzheimer's Diagnostics Market
Source: Streetwise Reports  (6/10/26)
Grey Matters Health advances its Alzheimer's neuroimaging strategy with fresh financing and plans for the first U.S. brain-specific PET clinic, capitalizing on rising demand for early detection tools. More >

Alzheimer's Diagnostic Clinic Initiative Moves Forward After Financing Close
Source: Streetwise Reports  (6/9/26)
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) closed the first CA$500,000 tranche of a financing that the company said will support its Alzheimer's disease program and planned U.S. brain-specific neuroimaging clinic. More >

Cancer Drug Developer Shifts 70% of Spending to Research as AI Pipeline Progresses
Source: Streetwise Reports  (6/5/26)
Rakovina Therapeutics (TSX.V: RKV) reported lower net losses, reduced administrative spending, debt restructuring, financing activity, and progress across its AI-driven oncology pipeline in Q1 2026. More >

New Alzheimer's Imaging Push Expands as Financing Terms Get Investor-Friendly
Source: Streetwise Reports  (5/29/26)
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) amended warrant terms tied to its CA$1 million private placement as it advances plans for a U.S. brain-specific neuroimaging clinic focused on Alzheimer's diagnostics. More >

200 Brain PET Scans, 162 Alzheimer's Drugs: A Diagnostic Push Takes Shape
Source: Streetwise Reports  (5/22/26)
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) signed an LOI tied to a minimum of 200 brain PET scans for an Alzheimer's clinical trial while expanding its NovaScan neuroimaging strategy. More >

Cleantech Co. Wins PFAS Deal, Engineering Pact, Ships Clyra
Source: Richard Ryan  (5/21/26)
BioLargo (BLGO:OTCQX) shipped Clyra's first stocking order, signed Aquatech PFAS MOU, and won a US$1.2M engineering contract for a minerals processing facility, according to an Oak Ridge Financial research note More >

Biotech Co. Unveils Scalable AI Voice Biomarker Platform
Source: Streetwise Reports  (5/13/26)
MindBio Therapeutics Corp.'s (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) CEO says proprietary AI voice analytics could transform impairment screening across zero-tolerance industries. More >

Biotech Co. Advances AI Detection Breakthrough for Intoxication Safety
Source: Streetwise Reports  (5/11/26)
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) enhances AI speech analysis tech with cross-language capability, paving the way for major accident-prevention potential. More >

CleanTech Company Advances Global PFAS Water Treatment Partnership with Aquatech
Source: Streetwise Reports  (5/8/26)
Cleantech and life sciences innovator BioLargo Inc. (BLGO:OTCQX) notches multiple wins this week for the distribution of its products worldwide. More >

Biotech Co. Finds Massive Physiological Screening Breakthrough
Source: Streetwise Reports  (4/29/26)
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) files patents for novel voice-biomarker intoxication detection, targeting applications in mining and aviation. More >

New York Healthcare Technology Co. Discovers Scalable Behavioral Health Breakthrough
Source: Streetwise Reports  (4/28/26)
DarioHealth Corp.'s (DRIO:NASDAQ) study showed measurable workplace productivity and cognitive function improvements in 1,254 users within weeks, boosting growth potential. More >

Biotech Firm Advances Voice-Based Intoxication Tech Aiming to Revolutionize Medical Diagnostics
Source: Streetwise Reports  (4/13/26)
MindBio Therapeutics Corp.'s (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) AI voice model analyzes 140+ biomarkers, targeting non-invasive impairment screening. More >

Canadian Biotech Co. Appoints Elite Regulatory Expert for Chile Expansion
Source: Streetwise Reports  (4/8/26)
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) appoints Chilean policy leader Felipe Leyton for the mining rollout of its AI impairment detection tech. More >

The World's First AI Voice Detection For Drugs & Alcohol With Charts That Beckon Investors To Buy
Source: Stewart Thomson  (4/1/26)
Technical Analyst Stewart Thomson explains why he thinks MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) is a Speculative Buy. More >

First US Brain-Only PET Clinic Targets Alzheimer's Detection as Diagnostic Demand Expands
Source: Streetwise Reports  (3/27/26)
Algernon Health (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is opening its inaugural brain PET clinic in Florida with a five-year lease and renewal option. More >

America's First Brain-Dedicated PET Scanning Clinics: A Turnaround Play for Chart-Savvy Investors?
Source: Stewart Thomson  (3/26/26)
Technical Analyst Stewart Thomson explains why he thinks Algernon Health (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is a Strong Speculative Buy. More >

Biotech Company Accelerates AI Detection Breakthrough Globally
Source: Streetwise Reports  (3/20/26)
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) advanced AI-powered screening kiosks, targeting safer operations across industrial sectors. More >

An AI-Powered Doctor & Patient Platform: Why This North American Provider is Gaining Market Momentum
Source: Stewart Thomson  (3/17/26)
Technical Analyst Stewart Thomson explains why he likes Rocket Doctor AI Inc. (AIDR:CSE; TREIF:OTC; 939:FRA). More >

Biotech Expands Financing to CA$2M as AI-Driven Cancer Drug Programs Advance
Source: Streetwise Reports  (2/24/26)
Rakovina Therapeutics Inc. (RKV:TSX.V) increased its previously announced financing to approximately US$2.0 million through a convertible debenture and private placement. The company stated the proceeds will support working capital needs and ongoing corporate and strategic initiatives. More >

AI Collaboration Expands to Accelerate Cancer Drug Discovery
Source: Streetwise Reports  (1/12/26)
Rakovina Therapeutics Inc. (RKV:TSX.V) has broadened its partnership with Variational AI to refine next-generation ATR inhibitors using generative AI. The agreement aims to streamline lead optimization for the company's kt-5000 series of small-molecule cancer drug candidates. More >